BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25068235)

  • 1. Fusidic acid in skin infections and infected atopic eczema.
    Bonamonte D; Belloni Fortina A; Neri L; Patrizi A
    G Ital Dermatol Venereol; 2014 Aug; 149(4):453-9. PubMed ID: 25068235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
    Mitra A; Mohanraj M; Shah M
    Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusidic acid betamethasone lipid cream.
    Girolomoni G; Mattina R; Manfredini S; Vertuani S; Fabrizi G
    Int J Clin Pract; 2016 May; 70 Suppl 184():4-13. PubMed ID: 27121235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
    Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
    Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy in the management of atopic dermatitis.
    Belloni Fortina A; Neri L
    G Ital Dermatol Venereol; 2015 Jun; 150(3):321-5. PubMed ID: 25786482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance.
    Heng YK; Tan KT; Sen P; Chow A; Leo YS; Lye DC; Chan RK
    Int J Dermatol; 2013 Jul; 52(7):876-81. PubMed ID: 23432159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
    Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis?
    Moody MN; Morrison LK; Tyring SK
    Skin Therapy Lett; 2010 Jan; 15(1):1-4. PubMed ID: 20066388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications.
    Abeck D; Mempel M
    Br J Dermatol; 1998 Dec; 139 Suppl 53():13-6. PubMed ID: 9990408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
    Kircik LH
    J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
    Ravenscroft JC; Layton AM; Eady EA; Murtagh MS; Coates P; Walker M; Cove JH
    Br J Dermatol; 2003 May; 148(5):1010-7. PubMed ID: 12786834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis.
    Suh L; Coffin S; Leckerman KH; Gelfand JM; Honig PJ; Yan AC
    Pediatr Dermatol; 2008; 25(5):528-34. PubMed ID: 18950393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to reduce Staphylococcus aureus in the management of atopic eczema.
    Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD003871. PubMed ID: 18646096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial therapy for skin infections.
    Hirschmann JV
    Cutis; 2007 Jun; 79(6 Suppl):26-36. PubMed ID: 17649855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics.
    Hung SH; Lin YT; Chu CY; Lee CC; Liang TC; Yang YH; Wang LC; Chiang BL
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):51-6. PubMed ID: 17225720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incurable bacterial skin infection].
    Nishijima S; Namura S; Kawai S
    Nihon Rinsho; 1994 Feb; 52(2):479-84. PubMed ID: 8126906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.
    Niebuhr M; Mai U; Kapp A; Werfel T
    Exp Dermatol; 2008 Nov; 17(11):953-7. PubMed ID: 18557929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.